Steroid-responsive nivolumab-induced involuntary movement with anti-thyroid antibodies

4Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

We herein report a 68-year-old man with neurologic immune-related adverse events (irAEs) who exhibited nivolumab-induced steroid-responsive progressive ataxia, tremor, and anti-thyroid antibodies. His symptoms matched abnormalities on N-isopropyl-p-(123I)-iodoamphetamine single-photon emission computed tomography (SPECT) and dopamine transporter SPECT. Based on these clinical findings, we diagnosed the patient with a condition similar to the cerebellar type of Hashimoto’s encephalopathy with nivolumab-induced anti-thyroid antibodies. Neurologic irAEs can be difficult to diagnose due to their varied clinical courses and lack of specific examinations. Therefore, a comprehensive approach, including assessments of autoantibodies and functional imaging, might be important for the diagnosis of neurologic irAEs.

Cite

CITATION STYLE

APA

Maetani, Y., Nezu, T., Ueno, H., Aoki, S., Hosomi, N., & Maruyama, H. (2019). Steroid-responsive nivolumab-induced involuntary movement with anti-thyroid antibodies. Internal Medicine, 58(24), 3577–3581. https://doi.org/10.2169/internalmedicine.3200-19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free